CAS number: 427-51-0

General information about the Cyproterone Acetate active pharmaceutical ingredient

Cyproterone Acetate as active pharmaceutical ingredient (API) is steroidal antiandrogen and progestin medication. It has a variety of medical uses due to its ability to block the effects of androgens, and to act as a progestin. Cyproterone Acetate is also used in hormone therapies, such as hormone replacement therapy in menopausal women, or as part of combined oral contraceptives along with estrogens. Cyproterone Acetate API can be used in the treatment of gynecological disorders. Cyproterone Acetate comes as oral tablets. Cyproterone Acetate also comes mixed with estrogens for birth control.

Axplora manufactures Cyproterone Acetate API

Cyproterone Acetate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Cyproterone Acetate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Cyproterone Acetate API is commercially available as micronized grade specifically designed around various formulation requirements.Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Cyproterone Acetate API.
  • Therapeutic area Anti-Androgen
  • Monograph PH.EUR.
  • Available grade Micronized
  • Regulatory documentation US DMF
  • Produced in GRO